Atomo Diagnostics Passes All Ten Resolutions at 2026 Annual General Meeting

Manish Choudhary

05 November 2026 05:39 PM AEDT

Atomo Diagnostics Passes All Ten Resolutions at 2026 Annual General Meeting

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Atomo Diagnostics Limited (ASX:AT1) disclosed that all ten resolutions put to shareholders at its 2026 Annual General Meeting, held on Thursday 5 November 2026, were carried by poll, including the adoption of the remuneration report, director re-election, ratification of prior share issues, and approval of a 10% placement facility.

Key Points

All ten resolutions were conducted by poll and carried at the 2026 AGM held on 5 November 2026.
Resolution 3 ratified the prior issue of 90,909,091 ordinary shares and 45,454,536 options as part of a placement, passing with 99.01% of votes cast in favour.
Resolution 10, approving a 10% placement facility as a special resolution, was carried with 77.75% of votes cast in favour.
Resolutions 7, 8 and 9 approved the grant of options to Mr Patrick Cook, Mr Anthony May, and Dr Cheri Walker respectively.

Remuneration Report and Director Re-Election Results

The adoption of the remuneration report under Resolution 1 was carried with 238,629,349 votes in favour, representing 98.82% of votes cast, against 2,847,700 votes or 1.18%. Resolution 2, the re-election of Mr Patrick Cook as a director of the company, was carried with 260,347,888 votes in favour, representing 80.94% of votes cast, against 61,295,369 votes or 19.06%. All resolutions at the meeting were determined by poll pursuant to section 250JA of the Corporations Act 2001.

Ratification of Prior Share and Option Issues

Resolution 3, ratifying the prior issue of 90,909,091 ordinary shares and 45,454,536 options as part of a placement, was carried with 316,974,589 votes or 99.01% in favour. Resolution 4, ratifying the prior issue of broker options to joint lead managers, was carried with 318,875,494 votes or 99.01% in favour. Resolution 5, ratifying the prior issue of 1,348,480 ordinary shares and 674,229 options as part of the Share Purchase Plan, was carried with 318,939,836 votes or 99.09% in favour. Resolution 6, approving the Employee Option Plan, was carried with 258,990,754 votes or 98.90% in favour.

Option Grants to Directors and 10% Placement Facility Approval

Resolutions 7, 8 and 9 approved the grant of options to Mr Patrick Cook, Mr Anthony May, and Dr Cheri Walker and/or their respective nominees. Resolution 7 was carried with 78.78% of votes in favour, Resolution 8 with 78.78%, and Resolution 9 with 79.38%. Resolution 10, the approval of a 10% placement facility as a special resolution, was carried with 250,418,149 votes or 77.75% in favour, against 71,645,389 votes or 22.25%. The company disclosure was authorised by the Interim Managing Director and CEO on behalf of the Board.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.